IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION

Track this case

Case overview

Case Number:

2:16-md-02724

Court:

Pennsylvania Eastern

Nature of Suit:

Other Statutes: Anti-Trust

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

CYNTHIA M. RUFE

Firms

Companies

Government Agencies

Sectors & Industries:

  1. October 31, 2017

    State AGs Triple Size Of Generic Price-Fixing Litigation

    The 46 attorneys general accusing six drug companies of conspiring to fix the price of two generic drugs said Tuesday they're asking a Pennsylvania federal court for permission to massively expand their suit by targeting 12 more drug companies, 13 more drugs, and Mylan and Emcure executives.

  2. June 02, 2017

    6 Suits Say Mylan, Others Rigged Generic Drug Prices

    Mylan Inc., Fougera Pharmaceuticals Inc., Par Pharmaceuticals Inc. and other drugmakers conspired to jack up the prices of certain generic muscle relaxers, skin creams, antidepressants and blood pressure drugs, a Northeast U.S. pharmacy operator said in six separate antitrust lawsuits filed on Thursday as part of multidistrict litigation in Pennsylvania federal court.

  3. May 23, 2017

    Generic Drug Price-Fixing MDL Fuels Worries For Defendants

    The multidistrict litigation over alleged price-fixing of generic drugs recently consolidated in Pennsylvania's Eastern District has the potential to emerge as one of the thorniest court fights in the country, and some observers have raised concerns that the numerous defendants could make it harder for individual companies to avoid getting more deeply embroiled in the litigation.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!